Dear Member,

We know that fitting a high-quality New Medicine Service (NMS) into a busy dispensing workflow is a challenge. However, the NMS remains one of our most valuable tools for both patient safety and pharmacy sustainability.

To support your clinical delivery and streamline your consultations, we are launching a new weekly training initiative - The NMS Adherence Series.

We are moving away from standard "tick-box" checklists. Instead, we will be sending you 2-3 distinct Clinical Infographics per week. These are designed using an "Adherence Engineering” philosophy, focusing specifically on the Therapeutic Gap (the delay between side effects and benefit) where most patients drop off.

Why this matters:

Clinical Confidence: These visual aids explain the mechanism of side effects, helping you deliver authoritative, reassuring advice that keeps patients on therapy.

Revenue Growth: High-quality consultations lead to higher completion rates. Maximizing our NMS quota is essential for the pharmacy's financial health.

Efficiency: Concise, visual data allows you to prep for a consultation in under 60 seconds.

This Week’s Focus

We are kicking off with two high-impact conditions:

• Atrial Fibrillation (DOACs): Addressing "Bleeding Anxiety" to prevent stroke risk.
• Parkinson’s Disease: Why exact timing is non-negotiable for motor control.

Please review the attached guides. Let’s use these to bridge the gap for our patients and drive our service numbers up.

Mandatory Clinical Disclaimer: Pharmacists must always verify information against current sources. The materials provided in this series are visual training aids designed for educational purposes only. They should not be relied upon to make clinical decisions. Professional clinical judgement must be exercised at all times, and the latest SPC, BNF, and NICE guidelines must be consulted. The authors accept no liability for clinical errors.

Regards,

PharmaPlus